The pan-BET inhibitor JQ1 robustly inhibited skeletal muscle differentiation marker transcript levels, suggesting a potential role of BET-BD1 in muscle cell differentiation, and raises questions about possible limitations in the therapeutic utility of pan-BETi in FSHD. The gene discussed is DNER; the disease is facioscapulohumeral muscular dystrophy.